Pharmacology of the lower urinary tract.
Recent advances in our understanding of the neurophysiology and neuropharmacology of the lower urinary tract have improved our ability to treat disorders of bladder and urethral function. Similarly, many classes of drugs used in treating various medical conditions can cause lower urinary-tract symptoms and dysfunction. Based on objective urodynamic evaluation, the clinician is able to sort out bladder and urethral abnormalities and scientifically choose appropriate pharmacologic regimes to treat these conditions. This article reviews lower urinary-tract physiology and provides the clinician with a rational, objective, neuro-pharmacologic approach to lower urinary-tract disorders.
H P
HP
Drutz
Obstet Gynecol Surv. 1979 Jun;34(6):417-23
460743
J Urol. 1976 Dec;116(6):737-8
1003641
Invest Urol. 1973 Jan;10(4):293-4
4734217
Urology. 1977 Jan;9(1):95-106
556658
Arch Surg. 1975 Mar;110(3):247-50
234729
Can J Surg. 1979 Nov;22(6):515-8
40680
J Urol. 1977 Aug;118(2):302-5
894809
Br J Urol. 1976 Aug;48(4):235-8
963397
Scand J Urol Nephrol. 1983;17(3):261-5
6196840
Urology. 1978 May;11(5):531-5
566976
Acta Pharmacol Toxicol (Copenh). 1978;43 Suppl 1:5-14
371336
J Urol. 1974 Jul;112(1):81-8
4601044
J Urol. 1973 Apr;109(4):625-6
4695101
J Urol. 1976 May;115(5):481-6
775133
Urology. 1975 May;5(5):616-23
236615
Urology. 1977 Jan;9(1):113-8
318783
Urol Clin North Am. 1974 Feb;1(1):3-27
4372763